Richard Spaide, MD
Ophthalmology · New York, NYNPI 1730281957
Payments from drug & device makers
Across 196 payments — averaging $8837.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Topcon Healthcare, Inc.$1.3M
- Heidelberg Engineering, Inc.$201K
- F. Hoffmann-la Roche AG$75K
- Regeneron$25K
- Canon Inc.$24K
- Genentech, Inc.$23K
- plus $52K from 22 others
Across 1 payment — averaging $687.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$688
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Topcon Healthcare, Inc. | 57 | $1,331,450 |
| Heidelberg Engineering, Inc. | 8 | $201,048 |
| F. Hoffmann-la Roche AG | 9 | $74,884 |
| Regeneron | 8 | $25,228 |
| Canon Inc. | 3 | $24,423 |
| Genentech, Inc. | 14 | $22,748 |
| Topcon Corporation | 12 | $21,038 |
| Dutch Ophthalmic Research Center (international) B.v. | 2 | $7,093 |
| Janssen Global Services, LLC | 10 | $6,568 |
| Merck | 12 | $6,269 |
| Alcon Research LLC | 3 | $3,800 |
| Boehringer Ingelheim | 1 | $1,900 |
| Alcon | 3 | $1,519 |
| Eyepoint US, Inc. | 2 | $1,410 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $832 |
| Bausch & Lomb Americas Inc. | 6 | $467 |
| Genentech USA, Inc. | 17 | $427 |
| Carl Zeiss Meditec, Inc. | 1 | $310 |
| Topcon Healthcare Solutions, Inc. | 1 | $276 |
| Dutch Ophthalmic, USA | 1 | $109 |
| Regeneron Healthcare Solutions, Inc. | 3 | $102 |
| Apellis Pharmaceuticals, Inc. | 3 | $90 |
| Tarsus Pharmaceuticals, Inc. | 3 | $74 |
| Novartis | 4 | $73 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Amgen | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Alimera Sciences, Inc. | 1 | $20 |
How this compares
$1,732,244 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in New York
- Douglas JabsNew York$24.3M
- Nathan RadcliffeNew York$2.4M
- Jason SlakterNew York$1.2M
- David ChuNew York$1.2M
- Sharon KehNew York$941K
- Joshua YoungNew York$814K
- Joseph PanarelliNew York$704K
- Joshua KimNew York$677K
- Eric RosenbergNew York$526K
- Ashley BrissetteNew York$452K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.